US to deliver Pfizer/BioNTech COVID-19 vaccine shipments on Monday
- The U.S. officials say the COVID-19 vaccine shipments from Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) will reach the states from Monday morning.
- The chief operating officer of Operation Warp Speed, Gustave F. Perna, says UPS and FedEx will deliver Pfizer’s vaccine to nearly 150 state locations, with another 450 sites set to receive the first doses on Tuesday and Wednesday.
- Yesterday, following the recommendation of an outside expert panel, the mRNA-based vaccine, BNT162b2, from the two companies, received the FDA’s emergency use authorization against COVID-19 in individuals 16 years of age or older. Based on additional data gathered from the ongoing Phase 3 clinical trial, Pfizer and BioNTech are seeking full regulatory approval in 2021, the companies said.
- If the rival candidate from Moderna (NASDAQ:MRNA), undergoing a similar review next week, wins the EUA nod, the U.S. aims to vaccinate 20M people in December followed by another 30M and 50M in January and February, respectively.
- The participants in the COVID-19 vaccine trial involving nearly 44,000 individuals ‘are courageous volunteers who have made a personal and important choice to help make a difference during this pandemic,’ the companies said, adding that the recipients of the placebo will have an option ‘to receive the vaccine at scheduled time points in the study.’
- https://seekingalpha.com/news/3643894-us-to-deliver-pfizer-biontech-covidminus-19-vaccine-shipments-on-monday
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.